Bristol Myers Squibb Strengthens its Commitment to the Environment with New Corporate Goals Biotech Investing
KEYTRUDA® Plus LENVIMA® Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective Response Rate Versus Chemotherapy in Patients With Advanced... Pharmaceutical Investing
Kite's Tecartus Granted Conditional Marketing Authorization for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma in Europe Biotech Investing
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity Biotech Investing
Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® Biotech Investing
Seelos Therapeutics Announces the Selection of SLS-005 for the HEALEY ALS Platform Trial for Amyotrophic Lateral Sclerosis Led by the Harvard Medical School Psychedelics Investing
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test Medical Device Investing
Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study Biotech Investing
Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming Cannabis Investing News
Health Canada Approves VENCLEXTA® in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia Biotech Investing
